Grants and Contributions:
Title:
COVID-19 Response Nitric Oxide to Prevent and Treat mild to moderate COVID-19 (Coronavirus disease 2019)
Agreement Number:
948557
Agreement Value:
$400,000.00
Agreement Date:
Apr 23, 2020 - Mar 31, 2021
Description:
Evaluating NORS Treatment for the Prevention and Treatment of COVID-19 in Healthcare Workers & Individuals at Risk of Infection.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
North Vancouver, British Columbia, CA V7H 2Y4
Reference Number:
172-2020-2021-Q1-948557
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
710549726
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 182 days.
Amendment Date
Sep 16, 2020
Recipient's Legal Name:
Sanotize Research & Development Corp.
Federal Riding Name:
Burnaby North--Seymour
Federal Riding Number:
59002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: